The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
MedMen Enterprises announced it signed an exclusive license agreement with Woodstock Ventures LC for the rights of the Woodstock brand in six US states.
MedMen Enterprises (CSE:MMEN) announced it signed an exclusive license agreement with Woodstock Ventures LC for the rights of the Woodstock brand in six US states.
As quoted in the press release:
MedMen Enterprises is pleased to announce it has signed an exclusive license agreement (the “Agreement”) with Woodstock Ventures LC and its affiliate The Woodstock Cannabis Company (collectively, “Woodstock”), granting MedMen rights to use the iconic Woodstock brand on cannabis products manufactured and sold in six states: California, Nevada, Massachusetts, Florida, Illinois and Arizona.
The Agreement grants MedMen the right to manufacture and distribute Woodstock branded cannabis products to MedMen stores or third-party retailers in those six states, and anticipates additional states should Woodstock decide to enter them. The Agreement also gives MedMen premium placement of cannabis products at Woodstock music festivals and promotions. Medical marijuana is currently legal in the six states covered by the agreement, adult-use is legal in California, Nevada and Massachusetts.
Click here to read the full press release.
Source: www.businesswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.